Position in ACLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$40,194,461
+$19,213,560 QoQ
Shares Held
350,065
+8.8% QoQ
Ownership
0.599%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. ACLX ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,194,461 | 350,065 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,980,901 | 321,793 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $27,466,634 | 334,551 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $22,782,452 | 345,975 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $26,491,967 | 403,841 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,499,111 | 410,733 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $32,076,857 | 384,108 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,348,509 | 350,580 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $25,000,442 | 359,460 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,169,865 | 363,421 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,184,140 | 367,451 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,368,970 | 359,550 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,200,512 | 266,164 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,580,778 | 276,978 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,793,031 | 255,356 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,748,769 | 96,724 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,207,177 | 86,104 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||